| Home | E-Submission | Sitemap | Contact Us |  
The Korean Journal of Pathology 1994;28(4): 381-388.
CD30 (Ber H2) Distribution in Hodgkin's Disease and non-Hodgkin's Lymphoma.
Bong Hee Kim, Young Hee Maeng, Ju Hie Lee, Moon Ho Yang
Department of Pathology, College of Medicine, Kyunghee University, Seoul, Korea.
ABSTRACT
Forty one cases of Hodgkin's disease and non-Hodgkin's lymphomas were immunohisto-chemi-cally studied for the presence of CD30 antigen on the paraffin embedded formaldehyde fixed tissue by using Ber H2(CD30) monoclonal antibody (Dakopatts, diluted l : 20) and avidin biotin peroxidase complex technique seventy five %(6/8) of Hodgkin's lymphoma and 27% (9/33) of non-Hodgkin's lymphomas were CD30 positive. Five of l7 diffuse large cell and immunoblastic lymphoma and one large cell anaplastic lymphoma showed large numbers of CD30 positive cells. Occasional CD30 positive cells were found in one of 2 angiommunoblastic lymphadenopathy-like T cell lymphoma, one of 4 small lymphocytic lymphoma and one unclassified lymphoma. Immunophenotypically l6% of B cell lymphoma and 42% of T cell lymphoma showed CD30 positivity. six cases of Hodgkin's disease except lymphocyte predominance showed positive tumor cells. Our results show that CD30 is more widespread in histologic subtypes of lymphomas and is not specific for the diagnosis of Hodgkin's disease.
Key Words: CD30; Hodgkin's disease and Non-Hodgkin's lymphoma